About Utah Medical Products (NASDAQ:UTMD)
Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company's product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women's health center in hospitals, as well as products sold to outpatient clinics and physician's offices.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
Trailing P/E Ratio21.59
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$39.30 million
Price / Sales7.52
Cash Flow$3.98 per share
Price / Cash19.98
Book Value$21.82 per share
Price / Book3.64
Net Income$12.12 million
Return on Equity18.31%
Return on Assets16.40%
Frequently Asked Questions for Utah Medical Products (NASDAQ:UTMD)
What is Utah Medical Products' stock symbol?
Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."
How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?
Utah Medical Products declared a quarterly dividend on Tuesday, October 31st. Investors of record on Friday, December 15th will be paid a dividend of $0.27 per share on Wednesday, January 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend is Thursday, December 14th. This is an increase from Utah Medical Products's previous quarterly dividend of $0.27. View Utah Medical Products' Dividend History.
How were Utah Medical Products' earnings last quarter?
Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings results on Tuesday, April, 25th. The medical instruments supplier reported $0.95 earnings per share for the quarter. The medical instruments supplier earned $10.26 million during the quarter. Utah Medical Products had a return on equity of 18.31% and a net margin of 34.31%. View Utah Medical Products' Earnings History.
When will Utah Medical Products make its next earnings announcement?
Who are some of Utah Medical Products' key competitors?
Some companies that are related to Utah Medical Products include Consort Medical plc (CSRT), Transenterix (TRXC), Surmodics (SRDX), Syneron Medical (ELOS), Antares Pharma (ATRS), Sientra (SIEN), Palomar Medical Technologies (PMTI), T2 Biosystems (TTOO), CRH Medical (CRHM), SeaSpine Holdings Corporation (SPNE), Ocular Therapeutix (OCUL), Bioquell plc (BQE), Tandem Diabetes Care (TNDM), Surgical Innovations Group plc (SUN), Capnia (SLNO), Cytori Therapeutics (CYTX), Alliqua BioMedical (ALQA) and Lombard Medical (EVARF).
Who are Utah Medical Products' key executives?
Utah Medical Products' management team includes the folowing people:
- Kevin L. Cornwell, Chairman of the Board, President, Chief Executive Officer and Secretary (Age 68)
- Paul O. Richins, Principal Financial Officer, Chief Administrative Officer, Vice President, Treasurer, Assistant Secretary, Director (Age 54)
- Ernst G. Hoyer, Lead Independent Director (Age 77)
- James H. Beeson M.D. Ph.D., Independent Director (Age 74)
- Barbara A. Payne Ph.D., Independent Director (Age 68)
Who owns Utah Medical Products stock?
Utah Medical Products' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.36%), American Century Companies Inc. (1.80%), Russell Investments Group Ltd. (1.35%), JPMorgan Chase & Co. (0.93%), Royce & Associates LP (0.92%) and Bank of New York Mellon Corp (0.76%). Company insiders that own Utah Medical Products stock include Ernst G Hoyer, Kevin L Cornwell and Paul O Richins. View Institutional Ownership Trends for Utah Medical Products.
Who sold Utah Medical Products stock? Who is selling Utah Medical Products stock?
Who bought Utah Medical Products stock? Who is buying Utah Medical Products stock?
Utah Medical Products' stock was acquired by a variety of institutional investors in the last quarter, including OxFORD Asset Management LLP, Wells Fargo & Company MN, Nationwide Fund Advisors, Bessemer Group Inc., Dimensional Fund Advisors LP, Russell Investments Group Ltd., Janney Montgomery Scott LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for Utah Medical Products.
How do I buy Utah Medical Products stock?
Shares of Utah Medical Products can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Utah Medical Products' stock price today?
One share of Utah Medical Products stock can currently be purchased for approximately $79.45.
How big of a company is Utah Medical Products?
Utah Medical Products has a market capitalization of $295.60 million and generates $39.30 million in revenue each year. The medical instruments supplier earns $12.12 million in net income (profit) each year or $3.68 on an earnings per share basis. Utah Medical Products employs 184 workers across the globe.
How can I contact Utah Medical Products?
Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.
MarketBeat Community Rating for Utah Medical Products (UTMD)MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Utah Medical Products (NASDAQ:UTMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Utah Medical Products (NASDAQ:UTMD)
Analysts' Ratings History for Utah Medical Products (NASDAQ:UTMD)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History and Estimates Chart for Utah Medical Products (NASDAQ:UTMD)
Earnings History by Quarter for Utah Medical Products (NASDAQ UTMD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/25/2017||Q1 2017||$0.95||$10.26 million||View||N/A|
|2/2/2016||Q415||$0.85||$10.20 million||$9.58 million||View||N/A|
|7/24/2014||Q214||$0.69||$0.75||$10.00 million||$10.49 million||View||N/A|
|1/30/2014||Q413||$0.64||$0.91||$9.83 million||$10.09 million||View||N/A|
|7/25/2013||Q2 2013||$0.62||$0.70||$10.03 million||$10.00 million||View||N/A|
|4/25/2013||Q113||$0.73||$11.21 million||$10.37 million||View||N/A|
|1/31/2013||Q4 2012||$0.60||$9.90 million||$9.80 million||View||N/A|
Earnings Estimates for Utah Medical Products (NASDAQ:UTMD)
No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for Utah Medical Products (NASDAQ:UTMD)
|Payout Ratio:||28.80% (Trailing 12 Months of Earnings) |
Dividend History by Quarter for Utah Medical Products (NASDAQ UTMD)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Utah Medical Products (NASDAQ UTMD)
Insider Ownership Percentage: 9.10%
Institutional Ownership Percentage: 65.92%
Insider Trades by Quarter for Utah Medical Products (NASDAQ UTMD)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/12/2016||Kevin L Cornwell||CEO||Sell||3,531||$69.25||$244,521.75|| |
|12/8/2016||Kevin L Cornwell||CEO||Sell||5,286||$70.10||$370,548.60|| |
|11/30/2016||Kevin L Cornwell||CEO||Sell||3,183||$69.03||$219,722.49|| |
|11/29/2016||Kevin L Cornwell||CEO||Sell||664||$69.00||$45,816.00|| |
|11/28/2016||Kevin L Cornwell||CEO||Sell||1,906||$69.05||$131,609.30|| |
|11/21/2016||Ernst G Hoyer||Director||Sell||362||$66.28||$23,993.36|| |
|11/17/2016||Ernst G Hoyer||Director||Sell||3,894||$66.30||$258,172.20|| |
|9/13/2016||Kevin L Cornwell||CEO||Sell||1,396||$63.09||$88,073.64|| |
|9/8/2016||Ernst G Hoyer||Director||Sell||63||$63.81||$4,020.03|| |
|9/7/2016||Kevin L Cornwell||CEO||Sell||408||$64.06||$26,136.48|| |
|8/31/2016||Kevin L Cornwell||CEO||Sell||716||$64.04||$45,852.64|| |
|8/29/2016||Kevin L Cornwell||CEO||Sell||2,200||$64.71||$142,362.00|| |
|8/15/2016||Kevin L Cornwell||CEO||Sell||23||$64.00||$1,472.00|| |
|8/10/2016||Kevin L Cornwell||CEO||Sell||1,800||$64.13||$115,434.00|| |
|5/31/2016||Paul O Richins||VP||Sell||396||$64.50||$25,542.00|| |
|5/27/2016||Paul O Richins||VP||Sell||271||$65.28||$17,690.88|| |
|11/10/2014||Kevin L Cornwell||CEO||Sell||3,472||$58.50||$203,112.00|| |
|3/14/2014||Ernst G Hoyer||Director||Sell||1,486||$56.04||$83,275.44|| |
|3/10/2014||Kevin L Cornwell||CEO||Sell||2,497||$55.45||$138,458.65|| |
|3/6/2014||Kevin L Cornwell||CEO||Sell||2,684||$55.69||$149,471.96|| |
|2/28/2014||Kevin L Cornwell||CEO||Sell||1,341||$55.48||$74,398.68|| |
|12/9/2013||Kevin L Cornwell||CEO||Sell||1,885||$51.65||$97,360.25|| |
|12/5/2013||Kevin L Cornwell||CEO||Sell||1,402||$51.55||$72,273.10|| |
|11/22/2013||Kevin L Cornwell||CEO||Sell||3,455||$53.13||$183,564.15|| |
|10/30/2013||Kevin L Cornwell||CEO||Sell||1,915||$56.40||$108,006.00|| |
|9/12/2013||Kevin L Cornwell||CEO||Sell||4,636||$50.50||$234,118.00|| |
|8/30/2013||Ernst G Hoyer||Director||Sell||10,000||$50.72||$507,200.00|| |
|8/23/2013||Kevin L Cornwell||CEO||Sell||5,715||$50.31||$287,521.65|| |
|7/31/2013||Kevin L Cornwell||CEO||Sell||8,100||$57.65||$466,965.00|| |
Latest Headlines for Utah Medical Products (NASDAQ UTMD)
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017|
finance.yahoo.com - November 16 at 9:37 AM
|Comparing OraSure Technologies (OSUR) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - November 4 at 5:46 PM
|Utah Medical Products, Inc. (UTMD) Declares Dividend Increase - $0.27 Per Share|
www.americanbankingnews.com - November 1 at 10:32 AM
|Utah Medical Products (UTMD) Raises Quarterly Dividend 1.9% to $0.27; 1.4% Yield|
www.streetinsider.com - October 31 at 11:37 AM
|Lice Clinics of America Opens New Treatment Center in South Charlotte to Treat Super Lice|
globenewswire.com - October 25 at 2:07 AM
|Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2017|
feeds.benzinga.com - October 24 at 9:53 AM
|Is Utah Medical Products Inc (UTMD) A Buy At Its Current Price?|
finance.yahoo.com - October 23 at 8:48 AM
|Is Utah Medical Products Inc (UTMD) A Buy At Its Current Price?|
finance.yahoo.com - October 23 at 8:48 AM
|Utah Medical Products (UTMD) and Its Competitors Financial Survey|
www.americanbankingnews.com - October 21 at 12:14 PM
|Utah Medical Products (UTMD) and Its Competitors Critical Comparison|
www.americanbankingnews.com - October 18 at 6:36 AM
|Utah Medical Products, Inc. (UTMD) Scheduled to Post Earnings on Monday|
www.americanbankingnews.com - October 16 at 3:50 AM
|Reviewing Bio-Rad Laboratories (BIO) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - October 7 at 12:18 AM
|Utah Medical Products, Inc. : UTMD-US: Dividend Analysis : September 15th, 2017 (record date) : By the numbers : October 4, 2017|
finance.yahoo.com - October 6 at 12:16 PM
|Cardiovascular Systems (CSII) and Utah Medical Products (UTMD) Head-To-Head Analysis|
www.americanbankingnews.com - October 1 at 12:18 PM
|Utah Medical Products (UTMD) and Its Rivals Head to Head Comparison|
www.americanbankingnews.com - September 26 at 12:32 PM
|Utah Medical Products goes ex-dividend tomorrow|
seekingalpha.com - September 13 at 10:50 AM
|Head-To-Head Comparison: Lombard Medical (EVAR) & Utah Medical Products (UTMD)|
www.americanbankingnews.com - September 8 at 4:14 PM
|3 Top Small-Cap Blend Mutual Funds for Attractive Returns|
www.zacks.com - August 29 at 9:21 AM
|Utah Medical Products (UTMD) vs. Landauer (LDR) Financial Comparison|
www.americanbankingnews.com - August 27 at 10:24 PM
|Utah Medical Products (UTMD) vs. Antares Pharma (ATRS) Head-To-Head Survey|
www.americanbankingnews.com - August 15 at 2:20 AM
|Utah Medical Products, Inc. :UTMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017|
finance.yahoo.com - August 5 at 8:14 AM
|Utah Medical Products, Inc. Declares Quarterly Dividend of $0.27 (UTMD)|
www.americanbankingnews.com - August 4 at 2:22 PM
|Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2017|
finance.yahoo.com - July 26 at 9:34 AM
|Utah Medical Products reports Q2 results|
seekingalpha.com - July 26 at 5:13 AM
|Utah Medical Products, Inc. (UTMD) Set to Announce Earnings on Monday|
www.americanbankingnews.com - July 22 at 10:23 AM
|Cash Dividend On The Way From Utah Medical Products (UTMD)|
www.thestreet.com - June 12 at 7:56 PM
|Utah Medical posts 1Q profit|
marketbeat.com - April 25 at 9:26 AM
|UTAH MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 9 at 4:04 AM
|BRIEF-Utah Medical Products Inc Q4 earnings per share of $0.725|
www.reuters.com - February 1 at 7:16 AM
|Utah Medical Products (UTMD) Declares $0.265 Quarterly Dividend; 1.7% Yield|
www.streetinsider.com - November 1 at 8:19 PM
|Utah Medical Products declares $0.265 dividend|
seekingalpha.com - November 1 at 8:19 PM
|BRIEF-Utah Medical Products Inc increases quarterly dividend by 2 pct to $0.265 per share|
www.reuters.com - November 1 at 8:19 PM
|Utah Medical Products goes ex-dividend today|
seekingalpha.com - September 15 at 11:40 AM
|Utah Medical reports Q4 and FY15 results|
seekingalpha.com - February 2 at 2:28 PM
|Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023|
www.prnewswire.com - January 28 at 2:06 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - November 6 at 3:38 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Other Events|
biz.yahoo.com - November 3 at 12:40 PM
|UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financial Condition|
biz.yahoo.com - October 22 at 1:39 PM
Utah Medical Products (NASDAQ UTMD) Chart for Friday, November, 24, 2017